Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03730181Phase 1Completed

Tuberculosis Clinical Trials Consortium Study 35

Role: collaborator

NCT04337450Phase 2Active Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Role: collaborator

NCT06164444Not ApplicableRecruiting

Disposable Versus Reusable DrApes and Gowns for Green OperatiNg Theatres

Role: collaborator

NCT05982847Recruiting

National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Role: collaborator

NCT05643781Completed

Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection

Role: collaborator

NCT03252119Not ApplicableTerminated

High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis

Role: lead

NCT03185637Completed

Children's Surgery in Sub-Saharan Africa

Role: collaborator

NCT02035306Not ApplicableCompleted

Usefulness of Non-invasive Pulse Co-oximetry Haemaglobin Measurements in Critically Ill Black Patients

Role: lead

All 8 trials loaded